BackAbCellera Biologics Overview

AbCellera Biologics Current Assets

AbCellera Biologics's current assets is $680M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$679.23M
8.48% YoYΔ $-62.91M vs prior year quarter

Peer trimmed avg / median

Loading

AbCellera Biologics Current Assets History

Loading

AbCellera Biologics vs. peers: Current Assets Comparison

Loading

AbCellera Biologics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AbCellera Biologics (ABCL) FAQ

As of the most recent data (June 2026), ABCL shows a current assets of $680M. That compares with $740M in the prior-year period — down 8.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABCL's current assets is now $680M (was $740M) — a 8.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AbCellera Biologics is outperforming or lagging.

Tracking ABCL's current assets over time shows whether AbCellera Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $680M That compares with $740M in the prior-year period — down 8.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has AbCellera Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $680M) with ownership activity and broader fundamentals.